Significance of PD-L1 expressing tumor cells in the combined positive score with triple negative breast cancer

被引：0
|
作者：
Evans, Tiffany [1 ]
Hund, Stephanie [1 ]
Krohn, Darlene [1 ]
Emancipator, Kenneth [2 ]
Juco, Jonathon [2 ]
Portier, Bryce [1 ]
Tabuena-Frolli, Siena [1 ]
Kulangara, Karina [1 ]
机构：
[1] Agilent, Carpinteria, CA USA
[2] Merck Sharp & Dohme Corp, Kenilworth, NJ USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PS4-15
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Role of PD-L1 expression in triple-negative breast cancer stem cells
    Di Nicola, Massimo A.
    Castagnoli, Lorenzo
    Cancila, Valeria
    Romero, Sandra
    Faraci, Simona
    Chiodoni, Claudia
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [12] Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1
    Li, Chia-Wei
    Lim, Seung-Oe
    Chung, Ezra M.
    Kim, Yong-Soo
    Park, Andrew H.
    Yao, Jun
    Cha, Jong-Ho
    Xia, Weiya
    Chan, Li-Chuan
    Kim, Taewan
    Chang, Shih-Shin
    Lee, Heng-Huan
    Chou, Chao-Kai
    Liu, Yen-Liang
    Yeh, Hsin-Chih
    Perillo, Evan P.
    Dunn, Andrew K.
    Kuo, Chu-Wei
    Khoo, Kay-Hooi
    Hsu, Jennifer L.
    Wu, Yun
    Hsu, Jung-Mao
    Yamaguchi, Hirohito
    Huang, Tzu-Hsuan
    Sahin, Aysegul A.
    Hortobagyi, Gabriel N.
    Yoo, Stephen S.
    Hung, Mien-Chie
    CANCER CELL, 2018, 33 (02) : 187 - +
  • [13] Eradication of triple-negative breast cancer cells by targeting glycosylated PD-L1
    Lim, Seung-Oe
    Li, Chia-Wei
    Hung, Mien-Chie
    CANCER RESEARCH, 2018, 78 (13)
  • [14] The effect of cardamonin on PD-L1 expression in triple-negative breast cancer cells
    Mendonca, Patricia
    Kirpal, Bhonessa
    Kaur, Sukhmandeep
    Soliman, Karam F. A.
    CANCER RESEARCH, 2024, 84 (06)
  • [15] Harmonizing PD-L1 testing in metastatic triple negative breast cancer
    Giugliano, Federica
    Antonarelli, Gabriele
    Tarantino, Paolo
    Cortes, Javier
    Rugo, Hope S.
    Curigliano, Giuseppe
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2022, 22 (03) : 345 - 348
  • [16] Expression and Clinical Significance of CMTM6 and PD-L1 in Triple-Negative Breast Cancer
    Shi, Shuai
    Ma, Hong-Yan
    Sang, Yin-zhou
    Ju, Ying-Bo
    Liu, Xiao-Yun
    Zhang, Zhi-Gang
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [17] Spatial Profile of Tumor Microenvironment in PD-L1-Negative and PD-L1-Positive Triple-Negative Breast Cancer
    Tashireva, Liubov A.
    Kalinchuk, Anna Yu.
    Gerashchenko, Tatiana S.
    Menyailo, Maksim
    Khozyainova, Anna
    Denisov, Evgeniy V.
    Perelmuter, Vladimir M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (02)
  • [18] Prognostic significance of EGFR, MUC1 and PD-L1 expressions in cases with triple negative breast cancer
    Mirili, Cem
    Paydas, Semra
    Kilic, Emine Bagir
    Seydaoglu, Gulsah
    Ogul, Ali
    Gokcay, Serkan
    Buyuksimsek, Mahmut
    Yetisir, Abdullah Evren
    Karaalioglu, Bilgin
    Tohumcuoglu, Mert
    Ergin, Melek
    Zorludemir, Suzan
    JOURNAL OF BUON, 2020, 25 (01): : 159 - 167
  • [19] PD-L1 expression in tumor infiltrated lymphocytes predicts survival in triple-negative breast cancer
    Wang Xinran
    Liu, Yueping
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (03)
  • [20] Effect of PD-1 and PD-L1 in the tumor microenvironment on overall survival of triple-negative breast cancer patients
    Linnaus, M. E.
    Kosiorek, H.
    Barrett, M. T.
    Dueck, A.
    Anderson, K. S.
    Ocal, I. T.
    McCullough, A. E.
    Annamalai, L.
    Yearley, J. H.
    Pockaj, B. A.
    CANCER RESEARCH, 2017, 77
12345